Dong-Gyu Jo Selected Research

Kv Channel-Interacting Proteins (Calsenilin)

7/2013	Calsenilin contributes to neuronal cell death in ischemic stroke.
2/2007	Neuronal vulnerability of CLN3 deletion to calcium-induced cytotoxicity is mediated by calsenilin.
2/2004	Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-beta exposure.
5/2003	Contribution of presenilin/gamma-secretase to calsenilin-mediated apoptosis.
4/2003	Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Gyu Jo Research Topics

Disease

34	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2003
17	Ischemic Stroke 10/2018 - 06/2006
12	Rheumatoid Arthritis 01/2021 - 03/2010
11	Neoplasms (Cancer) 01/2022 - 01/2002
11	Stroke (Strokes) 10/2018 - 05/2007
8	Experimental Arthritis 01/2021 - 03/2010
7	Ischemia 06/2018 - 02/2007
6	Cognitive Dysfunction 01/2022 - 01/2007
6	Hypoxia (Hypoxemia) 12/2021 - 05/2003
5	Inflammation (Inflammations) 01/2017 - 03/2010
4	Neuroblastoma 01/2021 - 09/2005
4	Brain Injuries (Brain Injury) 01/2021 - 08/2007
4	Obesity 10/2018 - 11/2015
4	Arthritis (Polyarthritis) 01/2018 - 01/2015
3	Memory Disorders (Memory Loss) 12/2021 - 05/2014
3	Amyloid Plaque 01/2019 - 09/2008
3	Infarction (Infarctions) 10/2018 - 07/2011
3	Brain Ischemia (Cerebral Ischemia) 06/2018 - 08/2007
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018 - 05/2007
3	AIDS-Related Complex (ARC) 11/2008 - 05/2003
2	Neuroinflammatory Diseases 01/2022 - 06/2017
2	Osteoporosis 10/2021 - 02/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 10/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2021 - 05/2014
2	Tauopathies 01/2019 - 11/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2014
2	Metabolic Diseases (Metabolic Disease) 10/2018 - 02/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 01/2014
2	Wounds and Injuries (Trauma) 09/2015 - 11/2007
2	Brain Infarction 01/2013 - 08/2007
2	Dementia (Dementias) 11/2011 - 02/2011
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Skin Diseases (Skin Disease) 05/2021
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2021
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Liver Diseases (Liver Disease) 10/2020
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Weight Gain 10/2018

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2003
22	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2021 - 05/2003
20	Amyloid (Amyloid Fibrils)IBA 01/2022 - 04/2005
12	Amyloid beta-PeptidesIBA 01/2022 - 02/2004
8	EnzymesIBA 01/2020 - 06/2006
6	Peptides (Polypeptides)IBA 01/2022 - 11/2011
5	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2013
5	Therapeutic UsesIBA 10/2021 - 03/2010
5	Hyaluronic Acid (Hyaluronan)IBA 01/2016 - 12/2010
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014 - 01/2002
5	Kv Channel-Interacting Proteins (Calsenilin)IBA 07/2013 - 04/2003
4	InflammasomesIBA 01/2022 - 07/2014
4	CollagenIBA 10/2020 - 12/2017
4	LigandsIBA 10/2018 - 03/2010
4	Pharmaceutical PreparationsIBA 10/2016 - 02/2014
4	PresenilinsIBA 01/2010 - 05/2003
3	CytokinesIBA 01/2022 - 02/2014
3	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 05/2007
3	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 02/2014
2	MicroRNAs (MicroRNA)IBA 10/2021 - 11/2015
2	RNA (Ribonucleic Acid)IBA 10/2021 - 11/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2019
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019 - 01/2019
2	PhytochemicalsIBA 10/2018 - 09/2016
2	DNA (Deoxyribonucleic Acid)IBA 06/2018 - 01/2007
2	Dextran SulfateIBA 01/2017 - 11/2013
2	Drug CarriersIBA 10/2016 - 02/2015
2	LipidsIBA 10/2016 - 08/2012
2	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2016 - 03/2014
2	polycaprolactoneIBA 02/2015 - 11/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2012 - 08/2007
2	Apoptosis Regulatory ProteinsIBA 07/2012 - 02/2007
2	CaspasesIBA 07/2011 - 11/2004
2	CalciumIBA 11/2008 - 11/2004
2	Glutamic Acid (Glutamate)FDA Link 11/2004 - 04/2003
1	TH 302IBA 01/2022
1	Pyruvate KinaseIBA 12/2021
1	OsteoprotegerinIBA 10/2021
1	Lysine (L-Lysine)FDA Link 09/2021
1	TubulinIBA 09/2021
1	Particulate MatterIBA 05/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Presenilin-1IBA 01/2021
1	Thioacetamide (Thioacetamid)IBA 10/2020
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2020
1	Green Fluorescent ProteinsIBA 01/2019
1	LuciferasesIBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Beclin-1IBA 01/2019
1	OsteopontinIBA 01/2019
1	ClusterinIBA 01/2019
1	benzofuranIBA 11/2018
1	sulfuretinIBA 10/2018
1	Activating Transcription Factor 3IBA 10/2018

Therapy/Procedure

15	Therapeutics 01/2022 - 08/2007
2	Drug Therapy (Chemotherapy) 01/2022 - 09/2014
2	Intravenous Administration 10/2021 - 01/2021
1	Radiotherapy 01/2022
1	Homologous Transplantation 10/2021
1	Liver Transplantation 10/2020